Literature DB >> 28222936

36 cases adenoid cystic carcinoma of the breast in China: Comparison with matched grade one invasive ductal carcinoma-not otherwise specified.

Shuling Wang1, Weidong Li2, Fang Wang3, Yun Niu2, Chunfang Hao1, Xu Wang1, Lihong He1, Zhongsheng Tong4.   

Abstract

OBJECTIVE: The aim of this study was to investigate the clinicopathological characteristic of adenoid cystic carcinoma (ACC).
MATERIALS AND METHODS: The clininopathological features, along with relapse free survival(RFS) and overall survival(OS) of 36 patients with ACC were retrospectively investigated and compared with those of 108 grade 1 invasive ductal carcinoma not-otherwise-specified (G1-IDC-NOS) patients.
RESULTS: Most cases of ACC were ER, PR and HER-2 negative which was classified as triple-negative subtype. Five cases were concomitant with other pathological types of cancer. Axillary lymph node dissection(ALND) was performed in 31 patients and 2 of them with lymph nodes metastasis. Two patients died of lung metastases at 46 and 116 months after the surgery respectively. Compared with G1-IDC-NOS, ACC showed lower Ki-67 index, less lymph nodes metastasis, lower P53 expression, and higher proportion in location of upper outer quadrant of breast. There was no difference of OS and RFS between ACC and G1-IDC-NOS.
CONCLUSIONS: ACC of the breast was a rare disease with a good prognosis although most of them were classified as triple-negative subtype. And the value of axillary node dissection and adjuvant therapy needs to be further investigated.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Adenoid cystic carcinoma (ACC); Breast cancer; Grade one invasive ductal carcinoma-not otherwise specified; Triple-negative breast carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28222936     DOI: 10.1016/j.prp.2017.01.021

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  6 in total

1.  The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.

Authors:  Christopher J Schwartz; Edi Brogi; Antonio Marra; Arnaud F Da Cruz Paula; Gouri J Nanjangud; Edaise M da Silva; Sujata Patil; Shreena Shah; Katia Ventura; Pedram Razavi; Larry Norton; Timothy D'alfonso; Britta Weigelt; Fresia Pareja; Jorge S Reis-Filho; Hannah Y Wen
Journal:  Mod Pathol       Date:  2021-10-01       Impact factor: 8.209

2.  Distinct clinicopathological and genomic features in solid and basaloid adenoid cystic carcinoma of the breast.

Authors:  Juan Ji; Fang Zhang; Fanglei Duan; Hong Yang; Jun Hou; Yang Liu; Jie Dai; Qiong Liao; Xian Chen; Qingsong Liu
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

3.  Seleno-short-chain chitosan induces apoptosis in human breast cancer cells through mitochondrial apoptosis pathway in vitro.

Authors:  Di Wu; Yana Zhao; Shengnan Fu; Jianbo Zhang; Wenhang Wang; Zhexian Yan; Heng Guo; Anjun Liu
Journal:  Cell Cycle       Date:  2018-08-02       Impact factor: 4.534

Review 4.  Triple negative breast cancer: special histological types and emerging therapeutic methods.

Authors:  Lu Cao; Yun Niu
Journal:  Cancer Biol Med       Date:  2020-05-15       Impact factor: 4.248

5.  Adenoid cystic carcinoma of the breast in a male: A case report.

Authors:  Wenyang Pang; Zhengyi Wang; Xiaoyan Jin; Qiang Zhang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

6.  Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer.

Authors:  Qian Yao; Wei Hou; Junbing Chen; Yanhua Bai; Mengping Long; Xiaozheng Huang; Chen Zhao; Lixin Zhou; Dongfeng Niu
Journal:  Front Med (Lausanne)       Date:  2022-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.